Collaboration Brings Researchers to a New Level of Discovery

2018 Steenbock Symposium program graphic. Source: University of Wisconsin-Madison Biochemistry Media Lab

At the 2018 40th Steenbock Symposium at University of Wisconsin-Madison, twenty-seven researchers from RNA and related fields convened at the Wisconsin Institute for Discovery to share “eureka” moments in their careers. It was so inspiring to hear from founding members of the RNA community, including Joan Steitz, Christine Guthrie, John Abelson, and Harry Noller. I noticed a recurring theme throughout the talks: many of these epiphanies resulted from informal meetings (quite often at a bar or social event) between colleagues in different groups, sometimes from different universities. They discussed tough problems and brainstormed about how to solve them, pondered about what their peculiar results could mean biologically, or dreamed, “wouldn’t it be cool if we could  <insert awesome idea here>?” and then came up with a way to do it. It sounded like a wonderful time to be a scientist! Sitting together freely sharing ideas, motivated by curiosity and the joy of doing science.

As I thought back to my research career to look for instances of such encounters, I was happy to find a few. “Philosophy” Meetings during grad school and Tea Time during my postdoc—informal social events to bring people together from different labs and departments with drinks and snacks. RNA Cluster Meetings during grad school and RNA MaxiGroup during my postdoc—events where people interested in a certain research area (in this case RNA) would gather for dinner and to hear an informal research talk. These organized events were intended to provide a forum for conversations between scientists to spark new ideas. Sometimes, I would talk to someone in a totally different field and learn something new. But I really didn’t have an epiphany about my own research. I often found myself (and others) scurrying away after the event to get back to lab work. Was I missing out on the best part of the meeting: the after-discussion?

My reflection on the Steenbock Symposium talks led me to ask a somewhat troubling question:

In today’s competitive research environment, have we missed out on crucial discoveries and technological advances because they weren’t given the right environment in which to develop?

Continue reading “Collaboration Brings Researchers to a New Level of Discovery”

Why Hasn’t the “Alternative” Become Mainstream?

Pearl Jam, a popular alternative rock band in the 1990s (and still pretty awesome!). Photo credit: Rolling Stone Magazine.

This post could easily start out as an ode to ’90s alternative music (of which I’m a huge fan). That new and totally different sound (a la Pearl Jam, Smashing Pumpkins, Soundgarden, Nirvana, etc.) in the 1990s eventually made its way into the mainstream as it gained popularity. (I have to say that I got a shock when I recently heard some Pearl Jam on “classic rock” radio stations. But I digress…)

Why isn’t the same true for science career paths? Science careers outside of academia are still referred to as “alternative.” In a previous post, I highlighted statistics from a 2012 NIH report that found that only 20% of recent life sciences Ph.D.’s go on to become faculty members1. That means that 80% of recent life sciences Ph.D.’s took the “alternative” path. It seems like the academic path could now be viewed as the alternative to the mainstream, but somehow there’s an underlying stigma associated with straying from a path which few can travel down successfully.

Continue reading “Why Hasn’t the “Alternative” Become Mainstream?”

Celebrating Women in Science

By US Environmental Protection Agency [Public domain], via Wikimedia Commons

February 11 is the International Day of Women and Girls in Science, a reminder that there is still a gender gap in science. Despite the obstacles that women need to overcome, their contributions to field of science have benefited not only their fellow researchers but also their fellow humans. From treatments for diseases to new discoveries that opened up entire fields, women have advanced knowledge across the spectrum of science. Below is a sampling of the achievements of just a few women in science. What other living female scientist or inventor might you add?

Hate malaria? You can thank Tu Youyou for discovering artemisinin and dihydroartemisinin, compounds that are used to treat the tropical disease and save numerous lives. Her discovery was so significant, she received the 2015 Nobel Prize in Physiology or Medicine.

Continue reading “Celebrating Women in Science”

Encouraging, Supporting, and Advocating for Diversity in Science

On December 27, 2017, the life sciences community lost a pioneer in neurobiology and an advocate for equality in science. Dr. Ben A. Barres passed away at the age of 63. His work focused on the critical role of glia (non-neuronal cells) in the brain and how they interface with neurons to maintain cognitive function.

Equally remarkable was the more personal side of his life. In 1997, Dr. Barbara Barres transitioned from female to male and lived the remainder of his life as Ben Barres. I read a number of the articles that Dr. Barres wrote and came across one that particularly caught my attention. In 2006 in response to several statements blaming gender imbalance in STEM fields on women’s innate in-aptitude, Ben wrote a Commentary in Nature that touched on his experience as a female scientist versus how he was treated as a male scientist. (Dr. Barres makes many very interesting points in the article, so I would encourage anyone to read it.) Prior to transitioning, he was often dismissed or interrupted but had a completely different experience as a male scientist. Dr. Barres even recounted that he overheard a colleague praising a seminar he gave, and adding that his work was “much better than his sister’s”1. The colleague was unaware that the research was the same and that he was talking about the same person. What a unique perspective to have been the one in the position of discrimination and then to be removed from it.

Continue reading “Encouraging, Supporting, and Advocating for Diversity in Science”

Optimizing Your Scientific Conference Experience

When I was in graduate school (a really long time ago), I remember going to my first big conference—American Society for Cell Biology—and being completely overwhelmed. I walked in with my Annual Conference Proceedings (back then it was all paper—no apps—and those books were thick, heavy and took up a ridiculous amount of space in your luggage). I had highlighted at least 100 posters that I was going to visit, along with one talk at every session that remotely applied to my work. And of course, I was not going to miss a single platform presentation. I was grimly determined to learn everything.

After a day-and-a-half, I was too tired to even troll the exhibition floor for freebies.

In my current job, I spend time monitoring hashtags for scientific conferences, and I occasionally notice a plaintive tweet from a conference attendee awash in a sea of posters and platform presentations—wondering where to start or where to stop.

So I asked our scientists at Promega what their tips are for getting the most out of a conference. Here are our Conference ProTips:

Continue reading “Optimizing Your Scientific Conference Experience”

Honoring Caregivers

This blog post is contributed by guest blogger Diana Clark, Benefits Manager, Promega Corporation

November is National Family Caregivers Month, first proclaimed by President Clinton in 1997, the proclamation has been renewed by every U.S. President since. When President Obama proclaimed this designation in 2012, he commented, “The unselfish devotion of family caregivers affirms the importance of respecting the dignity of life in all stages and underscores the importance of the family unit.”

Hearing these words, I felt even prouder to be a part of the Promega family. You see, we are already in the process of rolling out Caregiver Leave for 2018. Caregiver Leave will provide Promega employees with an additional three weeks of paid time off annually to care for a sick parent, spouse or child, or to welcome a new child into their family via birth, adoption or foster placement. Continue reading “Honoring Caregivers”

BioTech Scientists through a Different Lens

When I was in grad school and pictured what a role in industry would look like, the first thing that came to my mind was a Research and Development (R&D) Scientist. My life as a grad student and as a postdoc revolved around benchwork, so that must be the case in industry too, right?

It really wasn’t until I started working at Promega that this image of a scientist in industry was completely turned upside down (in a good way). Here are some roles that a scientist can assume at Promega: Senior Scientist, Research Scientist, R&D Group Leader, Production Scientist, Technical Services Scientist, Product Manager, Strategic Marketing Manager, Client Support Specialist, Client Support Consultant, Clinical Technical Consultant, Field Support Scientist, Applications Scientist, Scientific Instructional Designer. The list can probably go on for a while, but it makes the point that there are a variety of interesting positions for scientists in the biotech industry.
Continue reading “BioTech Scientists through a Different Lens”

A Nickel’s Worth of Free Advice: Biotech and the Law

This year’s participants in Emerging Techniques in Protein and Genetic Engineering, a two-credit graduate course offered in partnership with the Department of Oncology, UW-Madison, held July 17-21, 2017.

Today’s author extends thanks to Heather Gerard, Intellectual Property Manager, Promega Corporation for contributing her expertise to this post.

Students most often come to the BTC Institute with the primary goal of learning about molecular biology technologies. Our mission is to help them update their experimental tool-box, facilitating more capable studies of DNA, RNA and proteins back in their home laboratories.

But what else do we do? Well, we’re glad you asked.

Continue reading “A Nickel’s Worth of Free Advice: Biotech and the Law”

The University of Wisconsin Master of Science in Biotechnology Program Celebrates Its 15-Year Anniversary

The University of Wisconsin Master of Science in Biotechnology Program began with its first cohort of students in 2002, and its 14th class graduated this May, with the BTC Institute serving as a major partner since its inception. The 15-year anniversary highlights the success the program has garnered over the years, with over 300 alumni successfully completing the program between 2002 and 2017.

Kevin Conroy, JD led the panel discussion

To celebrate and acknowledge the program’s 15-year anniversary, a panel discussion was held in March of this year on the University of Wisconsin – Madison campus at the Wisconsin Institute for Medical Research (WIMR).  A panel of alumni and faculty, led by Kevin Conroy, CEO of Exact Sciences, addressed the question: What are the future education needs of the biotechnology industry in Wisconsin?

Continue reading “The University of Wisconsin Master of Science in Biotechnology Program Celebrates Its 15-Year Anniversary”